ESR1 and breast carcinoma: Tamoxifen, a selective estrogen receptor modulator, was approved by the Food and Drug Administration for the treatment of breast cancer since 1977.31 Despite its success in cancer chemotherapy, the multiple roles of tamoxifen in regulating estrogen receptors should be noticed.